Meglumine Diatrizoate is used in the treatment of diseases of bone, disease of muscle and disease of organs
How it works
Diatrizoate meglumine are sparingly absorbed from the intact gastrointestinal tract, and therefore permit gastrointestinal opacification and delineation after oral or rectal administration. Oral administration is used for radiographic evaluation of the esophagus, stomach and proximal small intestine. Rectal administration is used for examination of the colon. Enough absorption from the gastrointestinal tract to permit incidental visualization of the urinary tract.
Common side effects
Nausea, Shortness of breath, Anaphylactic reaction, Diarrhoea, Decreased oxygen level in blood, Tachyarrhythmia, Urticaria, Vomiting